Get the Stockscreener App
97.03
0.39%
0.38
After Hours:
97.03
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $97.03, with a volume of 7.84M.
It is up +0.39% in the last 24 hours and down -3.62% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$96.65
Open:
$97.1
24h Volume:
7.84M
Relative Volume:
1.05
Market Cap:
$124.39B
Revenue:
$35.48B
Net Income/Loss:
$4.64B
P/E Ratio:
27.09
EPS:
3.582
Net Cash Flow:
$5.41B
1W Performance:
-0.56%
1M Performance:
-3.62%
6M Performance:
+5.26%
1Y Performance:
+7.12%
1-Day Range:
$95.98
$97.60
1-Week Range:
$95.89
$98.98
52-Week Range:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
97.03 | 123.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
ABT
Abbott Laboratories
|
116.26 | 199.55B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
386.06 | 146.96B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
75.75 | 109.04B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.90 | 48.40B | 6.07B | 1.06B | 799.60M | 1.8527 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor - BioSpace
Medtronic (MDT) Launches MiniMed Go Smart MDI System in Europe - GuruFocus
1,326,614 Shares in Medtronic PLC $MDT Acquired by Magellan Asset Management Ltd - MarketBeat
Medtronic’s diabetes business MiniMed looks for $784m in US IPO - Medical Device Network
Medtronic’s MiniMed prices IPO at up to $784M - MedTech Dive
How Investors Are Reacting To Medtronic (MDT) Balancing Growth, Margin Pressure, And A Diabetes Spin-Off - simplywall.st
MiniMed IPO Seeks $784M, Valuing Medtronic Spin-Off at $7.86B - Medical Device and Diagnostic industry
Medtronic's Diabetes Spinoff MiniMed Seeks $742M IPO - Law360
Medtronic diabetes unit MiniMed seeks $784 million in US IPO - Yahoo Finance
Medtronic’s diabetes unit Minimed seeks $784M in IPO - bioworld.com
Medtronic (MDT) Subsidiary MiniMed Group Initiates IPO Roadshow - GuruFocus
Medtronic MiniMed Diabetes unit prices IPO at up to $784M - MassDevice
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off - FinancialContent
Medtronic Unit MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic diabetes unit MiniMed seeks $784 million in IPO By Investing.com - Investing.com Nigeria
MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic Plc Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
MiniMed announces launch of IPO roadshow - PR Newswire
Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO - Bloomberg
Miller Investment Management LP Sells 10,280 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic’s MiniMed seeks up to $784M in IPO (MMED:Pending) - Seeking Alpha
Nkcfo LLC Invests $8.04 Million in Medtronic PLC $MDT - MarketBeat
First Financial Bankshares Inc Buys 13,399 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic's MiniMed targets $7.9 billion valuation in US IPO - marketscreener.com
Medtronic's MiniMed aims to raise $784 million in US IPO - AOL.com
Medtronic's diabetes unit MiniMed eyes $7.9 billion valuation in US IPO - Reuters
Dakota Wealth Management Has $14.93 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic plc (MDT) Gains Momentum Through Diabetes and Cardiovascular Operations - Insider Monkey
Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight - GlobeNewswire Inc.
Clark Estates Inc. NY Has $21.43 Million Position in Medtronic PLC $MDT - MarketBeat
1 Reason I'd Buy Medtronic Stock and Never Sell - The Motley Fool
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash - The Motley Fool
EDENTREE ASSET MANAGEMENT Ltd Raises Position in Medtronic PLC $MDT - MarketBeat
Bleakley Financial Group LLC Purchases 13,177 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic (NYSE:MDT) Price Target Cut to $103.00 by Analysts at Truist Financial - MarketBeat
Medtronic: The Investment Appeal of a Medical Device Giant - Intellectia AI
Medtronic (NYSE:MDT) Upgraded at Mizuho - Defense World
Medtronic (NYSE:MDT) Rating Increased to Buy at Wall Street Zen - MarketBeat
Important takeaways from Medtronic’s (MDT) Q3 2026 earnings report - AlphaStreet News
Pharaoh Neuro raises $20m, picks ex-Medtronic exec for CEO role - Medical Device Network
Medtronic’s blood pressure device wins coverage nod in Japan - MedTech Dive
Medtronic to cut 81 employees at California diabetes site - MedTech Dive
Can Medtronic plc (2M6) stock withstand sector downturnsJuly 2025 Selloffs & Real-Time Buy Signal Notifications - mfd.ru
Medtronic PLC $MDT Shares Sold by Pekin Hardy Strauss Inc. - MarketBeat
Medtronic (NYSE:MDT) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
How Medtronic (NYSE:MDT) Reacts To Market Sentiment In S&P 500 Futures - Kalkine Media
Danaher Buys Masimo, Medtronic Grows, VB Spine Adds AR Tech - Medical Device and Diagnostic industry
Medtronic’s hypertension treatment receives reimbursement approval in Japan - Investing.com
Medtronic’s hypertension treatment receives reimbursement approval in Japan By Investing.com - Investing.com Nigeria
Medtronic sees first cases with Hugo robotic platform - BioWorld MedTech
Medtronic : Receives Reimbursement Approval for Symplicity Spyral™ Renal Denervation System in Japan - marketscreener.com
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.09%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):